Priar Robert J 4
4 · Bionano Genomics, Inc · Filed Jun 8, 2021
Insider Transaction Report
Form 4
Priar Robert J
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-01+400,000→ 400,000 totalExercise: $6.32Exp: 2031-06-01→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable on June 1, 2022, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from June 1, 2022, subject to Reporting Person's Continuous Service (as defined in the Company's 2018 Equity Incentive Plan) through each such applicable vesting date and the terms of the Company's 2018 Equity Incentive Plan.